Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: What is the current state of knowledge in humans?

Psychopharmacology

Volumn 231, Issue 17, 2014, Pages 3619-3634

  Crowley, Shannon K ^a   Girdler, Susan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Allopregnanolone; Allotetrahydrodeoxycorticosterone; Cortisol; Depression; DHEA; GABA; HPA axis; Neurosteroids; Premenstrual dysphoric disorder; Stress

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOTROPIN; DEOXYCORTICOSTERONE; GONADORELIN; NEUROSTEROID; TETRAGASTRIN; 4 AMINOBUTYRIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ACUTE STRESS; ALLOSTASIS; CHRONIC STRESS; GABAERGIC TRANSMISSION; HUMAN; HYPERACTIVITY; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MASS FRAGMENTOGRAPHY; MENTAL DISEASE; MENTAL STRESS; NEGATIVE FEEDBACK; NONHUMAN; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; REVIEW; SACCADIC EYE MOVEMENT; SOCIAL ISOLATION; SOCIAL STRESS; STRESS; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PHYSIOLOGY;

FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROTRANSMITTER AGENTS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 84923936636     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3572-8     Document Type: Review

References (203)

1. Agis-Balboa RC, Pinna G, Pibiri F, Kadriu B, Costa E, Guidotti A (2007) Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. Proc Natl Acad Sci U S A 104:18736-18741
2. Ahrens T, Deuschle M, Krumm B, van der Pompe G, den Boer JA, Lederbogen F (2008) Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom Med 70:461-467
3. Akk G, Covey DF, Evers AS, Steinbach JH, Zorumski CF, Mennerick S (2007) Mechanisms of neurosteroid interactions with GABA(A) receptors. Pharmacol Ther 116:35-57
4. Altemus M, Redwine LS, Leong YM, Frye CA, Porges SW, Carter CS (2001) Responses to laboratory psychosocial stress in postpartum women. Psychosom Med 63:814-821
5. Amato RJ, Lewis PB, He H, Winsauer PJ (2010) Effects of positive and negative modulators of the gamma-aminobutyric acid A receptor complex on responding under a differential-reinforcement-of-low-rate schedule of reinforcement in rats. Behav Pharmacol 8:8
6. Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH (2006) Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol Psychiatry 59:696-701
7. Backstrom T, Bixo M, Nyberg S, Savic I (2013) Increased neurosteroid sensitivity - an explanation to symptoms associated with chronic work related stress in women? Psychoneuroendocrinology 38:1078-1089
8. Barbaccia ML, Roscetti G, Trabucchi M, Mostallino MC, Concas A, Purdy RH, Biggio G (1996) Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 63:166-172
9. Barbaccia ML, Roscetti G, Trabucchi M, Purdy RH, Mostallino MC, Concas A, Biggio G (1997) The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol 120:1582-1588
10. Barbaccia ML, Concas A, Serra M, Biggio G (1998) Stress and neurosteroids in adult and aged rats. Exp Gerontol 33:697-712
11. Barden N (2004) Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29:185-193
12. Barrett-Connor E, von Muhlen D, Laughlin GA, Kripke A (1999) Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc 47:685-691
13. Baulieu E (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963-987
14. Belelli D, Lambert JJ (2005) Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6:565-575
15. Bellingrath S, Weigl T, Kudielka BM (2009) Chronic work stress and exhaustion is associated with higher allostastic load in female school teachers. Stress 12:37-48
16. Bifulco A, Brown G, Moran P, Ball C, Campbell C (1998) Predicting depression in women: the role of past and present vulnerability. Psychol Med 28:39-50
17. Biggio G, Concas A, Follesa P, Sanna E, Serra M (2007) Stress, ethanol, and neuroactive steroids. Pharmacol Ther 116:140-171
18. Binder EB, Nemeroff CB (2010) The CRF system, stress, depression and anxiety - insights from human genetic studies. Mol Psychiatry 15:574-588
19. Bitran D, Shiekh M, McLeod M (1995) Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 7:171-177
20. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR (1999) Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 45:1533-1541
21. Bockting CL, Lok A, Visser I, Assies J, Koeter MW, Schene AH (2012) Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study. Psychiatry Res 200:281-287
22. Brickley SG, Mody I (2012) Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron 73:23-34
23. Brilman EI, Ormel J (2001) Life events, difficulties and onset of depressive episodes in later life. Psychol Med 31:859-869
24. Browne ES, Wright BE, Porter JR, Svec F (1992) Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 303:366-371
25. Buckingham JC (2006) Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol 147:S258-S268
26. Burke HM, Davis MC, Otte C, Mohr DC (2005) Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30:846-856
27. Childs E, de Wit H (2009) Hormonal, cardiovascular, and subjective responses to acute stress in smokers. Psychopharmacology 203:1-12
28. Childs E, Van Dam NT, de Wit H (2010) Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Exp Clin Psychopharmacol 18:78-86
29. Chisari M, Eisenman LN, Covey DF, Mennerick S, Zorumski CF (2010) The sticky issue of neurosteroids and GABA(A) receptors. Trends Neurosci 33:299-306
30. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL (2002) Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord 70:125-132
31. Cullinan WE, Ziegler DR, Herman JP (2008) Functional role of local GABAergic influences on the HPA axis. Brain Struct Funct 213:63-72
32. Daly RC, Schmidt PJ, Davis CL, Danaceau MA, Rubinow DR (2001) Effects of gonadal steroids on peripheral benzodiazepine receptor density in women with PMS and controls. Psychoneuroendocrinology 26:539-549
33. D'Angelo B, Wierzbicki M (2003) Relations of daily hassles with both anxious and depressed mood in students. Psychol Rep 92:416-418
34. Decavel C, Van den Pol AN (1990) GABA: a dominant neurotransmitter in the hypothalamus. J Comp Neurol 302:1019-1037
35. Dhabhar FS (2009) Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 16:300-317
36. Dickerson SS, Kemeny ME (2004) Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 130:355
37. Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, Watanabe H, Costa E, Guidotti A (2001) Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci U S A 98:2849-2854
38. Droogleever Fortuyn HA, van Broekhoven F, Span PN, Backstrom T, Zitman FG, Verkes RJ (2004) Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29:1341-1344
39. Dubrovsky B (2006) Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol Biochem Behav 84:644-655
40. Engin E, Treit D (2007) The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol 18:461-470
41. Erdincler D, Bugay G, Ertan T, Eker E (2004) Depression and sex hormones in elderly women. Arch Gerontol Geriatr 39:239-244
42. Eriksson E, Sundblad C, Lisjo P, Modigh K, Andersch B (1992) Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 17:195-204
43. Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schule C, Rupprecht R, Romeo E (2005) Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers. Neuropsychopharmacology 30:192-195
44. Eser D, Romeo E, Baghai TC, di Michele F, Schule C, Pasini A, Zwanzger P, Padberg F, Rupprecht R (2006) Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138:1041-1048
45. Evans J, Sun Y, McGregor A, Connor B (2012) Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 63:1315-1326
46. Fabian TJ, Dew MA, Pollock BG, Reynolds CF 3rd, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD (2001) Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry 50:767-774
47. Frye CA, Rhodes ME (2006) Infusions of 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3alpha,5alpha-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J Neuroendocrinol 18:960-975
48. Gangisetty O, Reddy DS (2010) Neurosteroid withdrawal regulates GABA-A receptor alpha4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway. Neuroscience 170:865-880
49. Gartside SE, Griffith NC, Kaura V, Ingram CD (2010) The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABAA receptors. J Psychopharmacol 24:1717-1724
50. Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A, Nappi RE, Luisi S, Palumbo M, Purdy RH, Luisi M (1998) Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83:2099-2103
51. Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR (2003) Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril 80:1495-1501
52. Geronimus AT, Hicken M, Keene D, Bound J (2006) "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health 96:826-833
53. Gillespie CF, Nemeroff CB (2005) Hypercortisolemia and depression. Psychosom Med 67:S26-S28
54. Girdler SS, Pedersen CA, Stern RA, Light KC (1993) Menstrual cycle and premenstrual syndrome: modifiers of cardiovascular reactivity in women. Health Psychol 12:180-192
55. Girdler SS, Pedersen CA, Straneva PA, Leserman J, Stanwyck CL, Benjamin S, Light KC (1998) Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. Psychiatry Res 81:163-178
56. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788-797
57. Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA, Pedersen CA, Light KC (2003) Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med 65:849-856
58. Girdler SS, Beth Mechlin M, Light KC, Leslie Morrow A (2006) Ethnic differences in allopregnanolone concentrations in women during rest and following mental stress. Psychophysiology 43:331-336
59. Girdler SS, Leserman J, Bunevicius R, Klatzkin R, Pedersen CA, Light KC (2007) Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder. Health Psychol 26:201-213
60. Girdler SS, Lindgren M, Porcu P, Rubinow DR, Johnson JL, Morrow AL (2012) A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 37:543-553
61. Golding JM, Taylor DL, Menard L, King MJ (2000) Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. J Psychosom Obstet Gynaecol 21:69-80
62. Goodyer IM, Herbert J, Tamplin A (2003) Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychol Med 33:601-610
63. Groeneweg FL, Karst H, de Kloet ER, Joels M (2011) Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 209:153-167
64. Guazzo E, Kirkpatrick P, Goodyer I, Shiers H, Herbert J (1996) Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81:3951-3960
65. Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E (2001) The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev 37:110-115
66. Guo AL, Petraglia F, Criscuolo M, Ficarra G, Nappi RE, Palumbo MA, Trentini GP, Purdy RH, Genazzani AR (1995) Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. Gynecol Endocrinol 9:1-7
67. Halbreich U (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 3:55-99
68. Hansen CR Jr, Kroll J, Mackenzie TB (1982) Dehydroepiandrosterone and affective disorders. Am J Psychiatry 139:386-387
69. Harkin A, Kelly JP, Leonard BE (2003) A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clin Neurosci Res 3:253-262
70. Hennebert O, Chalbot S, Alran S, Morfin R (2007) Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol 104:326-333
71. Herman JP (2013) Neural control of chronic stress adaptation. Front Behav Neurosci 7:00061
72. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE (2003) Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24:151-180
73. Heuser I, Deuschle M, Luppa P, Schweiger U, Standhardt H, Weber B (1998) Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83:3130-3133
74. Hornsby PJ (1995) Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann N Y Acad Sci 774:29-46
75. Hutchinson JG, Williams PG (2007) Neuroticism, daily hassles, and depressive symptoms: an examination of moderating and mediating effects. Personal Individ Differ 42:1367-1378
76. Imamura M, Prasad C (1998) Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 243:771-775
77. Izawa S, Sugaya N, Shirotsuki K, Yamada KC, Ogawa N, Ouchi Y, Nagano Y, Suzuki K, Nomura S (2008) Salivary dehydroepiandrosterone secretion in response to acute psychosocial stress and its correlations with biological and psychological changes. Biol Psychol 79:294-298
78. Izawa S, Saito K, Shirotsuki K, Sugaya N, Nomura S (2012) Effects of prolonged stress on salivary cortisol and dehydroepiandrosterone: a study of a two-week teaching practice. Psychoneuroendocrinology 37:852-858
79. Jeckel CM, Lopes RP, Berleze MC, Luz C, Feix L, Argimon II, Stein LM, Bauer ME (2010) Neuroendocrine and immunological correlates of chronic stress in 'strictly healthy' populations. Neuroimmunomodulation 17:9-18
80. Jones MT, Gillham B, Altaher AR, Nicholson SA, Campbell EA, Watts SM, Thody A (1984) Clinical and experimental studies on the role of GABA in the regulation of ACTH secretion: a review. Psychoneuroendocrinology 9:107-123
81. Kalia M (2002) Assessing the economic impact of stress - the modern day hidden epidemic. Metabolism 51:49-53
82. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W (1994) Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 131:99-104
83. Kask K, Gulinello M, Backstrom T, Geyer MA, Sundstrom-Poromaa I (2008) Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 33:2283-2290
84. Kavaliers M, Wiebe JP (1987) Analgesic effects of the progesterone metabolite, 3 alpha-hydroxy-5 alpha-pregnan-20-one, and possible modes of action in mice. Brain Res 415:393-398
85. Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299-316
86. Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156:837-841
87. Kendler KS, Kuhn J, Prescott CA (2004) The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 161:631-636
88. Kirschbaum C, Pirke KM, Hellhammer DH (1993) The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76-81
89. Kirschbaum C, Klauer T, Filipp SH, Hellhammer DH (1995a) Sex-specific effects of social support on cortisol and subjective responses to acute psychological stress. Psychosom Med 57:23-31
90. Kirschbaum C, Pirke KM, Hellhammer DH (1995b) Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication. Psychoneuroendocrinology 20:509-514
91. Klatzkin RR, Morrow AL, Light KC, Pedersen CA, Girdler SS (2006a) Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoneuroendocrinology 31:1208-1219
92. Klatzkin RR, Morrow AL, Light KC, Pedersen CA, Girdler SS (2006b) Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol Psychol 71:2-11
93. Klatzkin RR, Lindgren ME, Forneris CA, Girdler SS (2010) Histories of major depression and premenstrual dysphoric disorder: evidence for phenotypic differences. Biol Psychol 84:235-247
94. Kraemer RR, Synovitz LB, Gimpel T, Kraemer GR, Johnson LG, Castracane VD (2001) Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender. Metabolism 50:488-493
95. Kushnir MM, Blamires T, Rockwood AL, Roberts WL, Yue B, Erdogan E, Bunker AM, Meikle AW (2010) Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem 56:1138-1147
96. Labrie F, Luu-The V, Belanger A, Lin SX, Simard J, Pelletier G, Labrie C (2005) Is dehydroepiandrosterone a hormone? J Endocrinol 187:169-196
97. Lac G, Dutheil F, Brousse G, Triboulet-Kelly C, Chamoux A (2012) Saliva DHEAS changes in patients suffering from psychopathological disorders arising from bullying at work. Brain Cogn 80:277-281
98. Le Melledo JM, Van Driel M, Coupland NJ, Lott P, Jhangri GS (2000) Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry 157:821-823
99. Lennartsson AK, Kushnir MM, Bergquist J, Jonsdottir IH (2012) DHEA and DHEA-S response to acute psychosocial stress in healthy men and women. Biol Psychol 90:143-149
100. Lennartsson AK, Theorell T, Kushnir MM, Bergquist J, Jonsdottir IH (2013) Perceived stress at work is associated with attenuated DHEA-S response during acute psychosocial stress. Psychoneuroendocrinology 38:1650-1657
101. Leonard BE (1984) The olfactory bulbectomized rat as a model of depression. Pol J Pharmacol Pharm 36:561-569
102. Leonard BE, Tuite M (1981) Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22:251-286
103. Lewinsohn PM, Zeiss AM, Duncan EM (1989) Probability of relapse after recovery from an episode of depression. J Abnorm Psychol 98:107-116
104. Lombardi I, Luisi S, Quirici B, Monteleone P, Bernardi F, Liut M, Casarosa E, Palumbo M, Petraglia F, Genazzani AR (2004) Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol 18:79-87
105. Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383-406
106. Maayan R, Touati-Werner D, Ram E, Strous R, Keren O, Weizman A (2006) The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice. Pharmacol Biochem Behav 85:415-421
107. Majewska MD (1992) Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38:379-395
108. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30:65-91
109. Maninger N, Capitanio JP, Mason WA, Ruys JD, Mendoza SP (2010) Acute and chronic stress increase DHEAS concentrations in rhesus monkeys. Psychoneuroendocrinology 35:1055-1062
110. Marceau K, Dorn LD, Susman EJ (2012) Stress and puberty-related hormone reactivity, negative emotionality, and parent - adolescent relationships. Psychoneuroendocrinology 37:1286-1298
111. Marcilhac A, Anglade G, Hery F, Siaud P (1999) Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats. Neurosci Lett 262:89-92
112. Markopoulou K, Papadopoulos A, Juruena MF, Poon L, Pariante CM, Cleare AJ (2009) The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology 34:19-26
113. Matsumoto K, Pinna G, Puia G, Guidotti A, Costa E (2005) Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress 8:85-93
114. McEwen BS (1998) Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 840:33-44
115. McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873-904
116. McEwen BS (2008) Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583:174-185
117. McEwen BS, Getz L (2013) Lifetime experiences, the brain and personalized medicine: An integrative perspective. Metabolism 62(Supplement 1):S20-S26
118. McEwen BS, Seeman T (1999) Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci 896:30-47
119. Meczekalski B, Tonetti A, Monteleone P, Bernardi F, Luisi S, Stomati M, Luisi M, Petraglia F, Genazzani AR (2000) Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. Eur J Endocrinol 142:280-285
120. Menozzi R, Florio P, Bondi M, Luisi S, Cobellis L, Genazzani AR, Del Rio G, Petraglia F (2002) Increased response of plasma allopregnanolone to corticotropin-releasing hormone in obese patients. Neuroendocrinology 75:124-129
121. Michael A, Jenaway A, Paykel ES, Herbert J (2000) Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry 48:989-995
122. Miller GE, Chen E, Zhou ES (2007) If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull 133:25-45
123. Mommersteeg P, Heijnen CJ, Kavelaars A, van Doornen LJ (2007) The HPA-axis and immune function in burnout. Prog Brain Res 167:281-285
124. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142:269-273
125. Morrison MF, Ten Have T, Freeman EW, Sammel MD, Grisso JA (2001) DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years. Biol Psychiatry 50:705-711
126. Morrow AL (2007) Recent developments in the significance and therapeutic relevance of neuroactive steroids - introduction to the special issue. Pharmacol Ther 116:1-6
127. Morrow AL, Suzdak PD, Paul SM (1987) Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142:483-485
128. Morrow AL, Devaud LL, Purdy RH, Paul SM (1995) Neuroactive steroid modulators of the stress response. Ann N Y Acad Sci 771:257-272
129. Morsink LF, Vogelzangs N, Nicklas BJ, Beekman AT, Satterfield S, Rubin SM, Yaffe K, Simonsick E, Newman AB, Kritchevsky SB, Penninx BW (2007) Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the Health ABC study. Psychoneuroendocrinology 32:874-883
130. Myers B, McKlveen JM, Herman JP (2012) Neural regulation of the stress response: the many faces of feedback. Cell Mol Neurobiol 32:683-694
131. Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR (2001) Serum allopregnanolone in women with postpartum "blues". Obstet Gynecol 97:77-80
132. Nemeroff CB (1998) The neurobiology of depression. Sci Am Am Ed 278:42-49
133. Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 47:917-925
134. Oberbeck R, Kobbe P (2010) Dehydroepiandrosterone (DHEA): a steroid with multiple effects. Is there any possible option in the treatment of critical illness? Curr Med Chem 17:1039-1047
135. Owens MJ, Ritchie JC, Nemeroff CB (1992) 5 alpha-pregnane-3 alpha, 21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam. Brain Res 573:353-355
136. Paddison PL, Gise LH, Lebovits A, Strain JJ, Cirasole DM, Levine JP (1990) Sexual abuse and premenstrual syndrome: comparison between a lower and higher socioeconomic group. Psychosomatics 31:265-272
137. Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464-468
138. Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH (1999) Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res 830:72-87
139. Parker LN, Odell WD (1980) Control of adrenal androgen secretion. Endocr Rev 1:392-410
140. Patchev VK, Almeida OF (1996) Gonadal steroids exert facilitating and "buffering" effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. J Neurosci 16:7077-7084
141. Patchev VK, Hassan AH, Holsboer DF, Almeida OF (1996) The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15:533-540
142. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322
143. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski TA (1990) Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 20:129-134
144. Perry BL, Pullen E, Oser CB (2012) Too much of a good thing? Psychosocial resources, gendered racism, and suicidal ideation among low-SES African American women. Soc Psychol Q 75:334-359
145. Perry BL, Stevens-Watkins D, Oser CB (2013) The moderating effects of skin color and ethnic identity affirmation on suicide risk among low-SES African American women. Race Soc Probl 5:1-14
146. Pibiri F, Nelson M, Carboni G, Pinna G (2006) Neurosteroids regulate mouse aggression induced by anabolic androgenic steroids. Neuroreport 17:1537-1541
147. Pico-Alfonso MA, Mastorci F, Ceresini G, Ceda GP, Manghi M, Pino O, Troisi A, Sgoifo A (2007) Acute psychosocial challenge and cardiac autonomic response in women: the role of estrogens, corticosteroids, and behavioral coping styles. Psychoneuroendocrinology 32:451-463
148. Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A (2003) In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci U S A 100:2035-2040
149. Plotsky PM, Owens MJ, Nemeroff CB (1998) Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin N Am 21:293-307
150. Porcu P, O'Buckley TK, Alward SE, Marx CE, Shampine LJ, Girdler SS, Morrow AL (2009) Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum. Steroids 74:463-473
151. Purdy RH, Morrow AL, Moore PH Jr, Paul SM (1991) Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A 88:4553-4557
152. Raadsheer F, Hoogendijk WJ, Stam F, Tilders F, Swaab DF (1994) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436-444
153. Rabin DS, Schmidt PJ, Campbell G, Gold PW, Jensvold M, Rubinow DR, Chrousos GP (1990) Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J Clin Endocrinol Metab 71:1158-1162
154. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709-714
155. Reddy DS (2006) Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions. Neuroscience 138:911-920
156. Redei E, Freeman EW (1993) Preliminary evidence for plasma adrenocorticotropin levels as biological correlates of premenstrual symptoms. Acta Endocrinol 128:536-542
157. Richards JM, Stipelman BA, Bornovalova MA, Daughters SB, Sinha R, Lejuez CW (2011) Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work. Biol Psychol 88:1-12
158. Romeo E, Strohle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910-913
159. Sanna E, Cuccheddu T, Serra M, Concas A, Biggio G (1992) Carbon dioxide inhalation reduces the function of GABAA receptors in the rat brain. Eur J Pharmacol 216:457-458
160. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284-301
161. Schmidt PJ, Purdy RH, Moore PH Jr, Paul SM, Rubinow DR (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79:1256-1260
162. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR (2005) Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62:154-162
163. Segebladh B, Bannbers E, Moby L, Nyberg S, Bixo M, Bäckström T, Poromaa IS (2013) Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder. Arch Womens Ment Health 16:131-137
164. Serra M, Pisu MG, Littera M, Papi G, Sanna E, Tuveri F, Usala L, Purdy RH, Biggio G (2000) Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem 75:732-740
165. Serra M, Pisu MG, Floris I, Floris S, Cannas E, Mossa A, Trapani G, Latrofa A, Purdy RH, Biggio G (2004) Social isolation increases the response of peripheral benzodiazepine receptors in the rat. Neurochem Int 45:141-148
166. Serra M, Pisu M, Floris I, Biggio G (2005) Social isolation-induced changes in the hypothalamic-pituitary-adrenal axis in the rat. Stress 8:259-264
167. Shirotsuki K, Izawa S, Sugaya N, Yamada KC, Ogawa N, Ouchi Y, Nagano Y, Nomura S (2009) Salivary cortisol and DHEA reactivity to psychosocial stress in socially anxious males. Int J Psychophysiol 72:198-203
168. Simpson ER, Waterman MR (1988) Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50:427-440
169. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X (1998) GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392:926-930
170. Smith SS, Ruderman Y, Frye C, Homanics G, Yuan M (2006) Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 186:323-333
171. Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627-647
172. Sterling P, Eyer J (1988) Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J (eds) Handbook of Life Stress, Cognition and Health. J. Wiley & Sons, New York, NY, pp 629-649
173. Strohle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F, Holsboer F, Rupprecht R (1999) Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45:274-277
174. Strohle A, Pasini A, Romeo E, Hermann B, Spalletta G, di Michele F, Holsboer F, Rupprecht R (2000) Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. J Psychiatr Res 34:183-186
175. Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A (2003) Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60:133-141
176. Šulcová J, Hill M, Hampl R, Starka L (1997) Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 154:57-62
177. Sundstrom I, Ashbrook D, Backstrom T (1997a) Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 22:25-38
178. Sundstrom I, Nyberg S, Backstrom T (1997b) Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17:370-381
179. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Backstrom T (1998) Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67:126-138
180. Takebayashi M, Kagaya A, Uchitomi Y, Kugaya A, Muraoka M, Yokota N, Horiguchi J, Yamawaki S (1998) Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication. J Neural Transm 105:537-542
181. Turkmen S, Backstrom T, Wahlstrom G, Andreen L, Johansson IM (2011) Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol 162:311-327
182. Ulrich-Lai YM, Herman JP (2009) Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10:397-409
183. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95:3239-3244
184. Uzunova V, Ceci M, Kohler C, Uzunov DP, Wrynn AS (2003) Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression. Brain Res 976:1-8
185. Uzunova V, Sampson L, Uzunov DP (2006) Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology 186:351-361
186. Vallee M, Rivera JD, Koob GF, Purdy RH, Fitzgerald RL (2000) Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem 287:153-166
187. van Broekhoven F, Verkes RJ (2003) Neurosteroids in depression: a review. Psychopharmacology 165:97-110
188. Vedhara K, McDermott MP, Evans TG, Treanor JJ, Plummer S, Tallon D, Cruttenden KA, Schifitto G (2002) Chronic stress in nonelderly caregivers: psychological, endocrine and immune implications. J Psychosom Res 53:1153-1161
189. Wang M, Seippel L, Purdy RH, Backstrom T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81:1076-1082
190. Wichers M, Geschwind N, Jacobs N, Kenis G, Peeters F, Derom C, Thiery E, Delespaul P, van Os J (2009) Transition from stress sensitivity to a depressive state: longitudinal twin study. Br J Psychiatry 195:498-503
191. Williams DR, Yu Y, Jackson JS, Anderson NB (1997) Racial differences in physical and mental health socio-economic status, stress and discrimination. J Health Psychol 2:335-351
192. Wolf OT, Kirschbaum C (1999) Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev 30:264-288
193. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156:646-649
194. Wolkowitz OM, Epel ES, Reus VI (2001) Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry 2:115-143
195. Wong SY, Leung JC, Kwok T, Ohlsson C, Vandenput L, Leung PC, Woo J (2011) Low DHEAS levels are associated with depressive symptoms in elderly Chinese men: results from a large study. Asian J Androl 13:898-902
196. Woods NF, Lentz M, Mitchell ES, Heitkemper M, Shaver J (1997) PMS after 40: persistence of a stress-related symptom pattern. Res Nurs Health 20:329-340
197. Young EA, Veldhuis JD (2006) Disordered adrenocorticotropin secretion in women with major depression. J Clin Endocrinol Metab 91:1924-1928
198. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2000) Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology 23:411-418
199. Young AH, Gallagher P, Porter RJ (2002) Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry 159:1237-1239
200. Young EA, Abelson JL, Cameron OG (2004a) Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry 56:113-120
201. Young EA, Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, DeBattista C, Zubieta JK (2004b) HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology 29:1198-1204
202. Zheng P (2009) Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 89:134-152
203. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001) Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res 35:83-94